SEC Form 4 · accession 0001127602-18-017568
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Mackay
Director
Period of report
May 14, 2018
Accepted (ET)
May 16, 2018 · 6:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2018 | A | 2,004 | $0.00 | A | 4,786 | D | |
| Common Stock | May 14, 2018 | A | 560 | $0.00 | A | 5,346 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders.
- F2This grant was made in lieu of director service fees for the term commencing May 8, 2018. The restricted stock units vest upon the earlier of 5/14/2019 or the business day prior to the Company's next annual meeting of shareholders.